- Home
- NMG vs OSUR Comparison
NMG vs OSUR Comparison
Compare NMG & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMG
- OSUR
- Stock Information
- Founded
- NMG 2011
- OSUR 2000
- Country
- NMG Canada
- OSUR United States
- Employees
- NMG N/A
- OSUR N/A
- Industry
- NMG Other Metals and Minerals
- OSUR Medical/Dental Instruments
- Sector
- NMG Basic Materials
- OSUR Health Care
- Exchange
- NMG Nasdaq
- OSUR Nasdaq
- Market Cap
- NMG 245.1M
- OSUR 223.0M
- IPO Year
- NMG 2017
- OSUR 1986
- Fundamental
- Price
- NMG $1.71
- OSUR $3.00
- Analyst Decision
- NMG Strong Buy
- OSUR Hold
- Analyst Count
- NMG 2
- OSUR 1
- Target Price
- NMG $2.58
- OSUR $3.00
- AVG Volume (30 Days)
- NMG 44.4K
- OSUR 823.3K
- Earning Date
- NMG 08-13-2025
- OSUR 08-05-2025
- Dividend Yield
- NMG N/A
- OSUR N/A
- EPS Growth
- NMG N/A
- OSUR N/A
- EPS
- NMG N/A
- OSUR N/A
- Revenue
- NMG N/A
- OSUR $161,626,000.00
- Revenue This Year
- NMG N/A
- OSUR N/A
- Revenue Next Year
- NMG N/A
- OSUR $6.20
- P/E Ratio
- NMG N/A
- OSUR N/A
- Revenue Growth
- NMG N/A
- OSUR N/A
- 52 Week Low
- NMG $1.22
- OSUR $2.36
- 52 Week High
- NMG $2.58
- OSUR $4.92
- Technical
- Relative Strength Index (RSI)
- NMG 47.19
- OSUR 54.60
- Support Level
- NMG $1.70
- OSUR $2.78
- Resistance Level
- NMG $1.89
- OSUR $3.03
- Average True Range (ATR)
- NMG 0.07
- OSUR 0.13
- MACD
- NMG -0.01
- OSUR 0.01
- Stochastic Oscillator
- NMG 30.43
- OSUR 58.93
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.